A Counterfeit Addiction

The United States Food and Drug Administration (FDA) has issued warnings to four e-commerce agents regarding the illegal trade of opioids through online channels. The FDA had reason to believe that the opioids were unapproved, misbranded and potentially dangerous products being marketed as various medical substances. The FDA has warned the general public that medication sold through these types of websites are likely to be either counterfeit, expired or otherwise contaminated goods. The need for brand protection in the pharma industry has never been more urgent.

While counterfeiting in the clothing and accessories industry is a widespread issue that negatively affects society on many different levels, counterfeit medical products are dangerous in a different sense. Medication that reaches consumers without being submitted to any testing whatsoever is downright life-threatening.

The trade of counterfeit opioids is especially worrying as the substance is known to cause addiction and overdoses. In fact, the FDA states that 115 Americans die from an opioid overdose every day, and counterfeit opioid medicines rarely contain the warning messages and information regarding side-effects that legitimate products do. Though authorities are working hard to keep counterfeit medical products off the market, pharmaceutical companies are also encouraged to take action against fraudsters and thereby protect both their brand and consumers.

 

More on Brand Protection:

Our Services - Anti-Counterfeiting

Why Brand Protection is a Must for all Companies

#ImForReal - Take a stand against the market of counterfeit goods

Share on social media